[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Repligen Corp (RGEN)

Repligen Corp (RGEN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 8,136,291
  • Shares Outstanding, K 56,408
  • Annual Sales, $ 738,260 K
  • Annual Income, $ 48,890 K
  • EBIT $ 65 M
  • EBITDA $ 160 M
  • 60-Month Beta 1.06
  • Price/Sales 11.00
  • Price/Cash Flow 42.13
  • Price/Book 3.86

Options Overview Details

View History
  • Implied Volatility 59.43% (+1.66%)
  • Historical Volatility 51.74%
  • IV Percentile 95%
  • IV Rank 80.75%
  • IV High 65.02% on 04/27/26
  • IV Low 35.94% on 08/14/25
  • Expected Move (DTE 5) 7.87 (5.46%)
  • Put/Call Vol Ratio 0.00
  • Today's Volume 12
  • Volume Avg (30-Day) 230
  • Put/Call OI Ratio 1.73
  • Today's Open Interest 8,339
  • Open Int (30-Day) 8,524
  • Expected Range 136.37 to 152.11

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 21 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $0.46
  • Number of Estimates 5
  • High Estimate $0.49
  • Low Estimate $0.44
  • Prior Year $0.37
  • Growth Rate Est. (year over year) +24.32%

Price Performance

See More
Period Period Low Period High Performance
1-Month
124.85 +15.53%
on 06/23/26
149.05 -3.23%
on 06/25/26
+13.48 (+10.31%)
since 06/10/26
3-Month
100.99 +42.83%
on 05/14/26
149.05 -3.23%
on 06/25/26
+24.14 (+20.10%)
since 04/10/26
52-Week
100.99 +42.83%
on 05/14/26
175.77 -17.94%
on 01/06/26
+10.24 (+7.64%)
since 07/10/25

Most Recent Stories

More News
3 Reasons RGEN is Risky and 1 Stock to Buy Instead

3 Reasons RGEN is Risky and 1 Stock to Buy Instead

RGEN : 144.24 (+0.21%)
2 High-Flying Stocks on Our Watchlist and 1 We Find Risky

2 High-Flying Stocks on Our Watchlist and 1 We Find Risky

PLXS : 267.27 (-1.22%)
BELFA : 229.55 (+1.38%)
RGEN : 144.24 (+0.21%)
2 Profitable Stocks on Our Watchlist and 1 Facing Challenges

2 Profitable Stocks on Our Watchlist and 1 Facing Challenges

MO : 71.79 (+0.28%)
AMP : 506.76 (+1.32%)
RGEN : 144.24 (+0.21%)
Repligen Corporation to Present at William Blair 46th Annual Growth Stock Conference

WALTHAM, Mass., May 22, 2026 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will participate in...

RGEN : 144.24 (+0.21%)
3 Out-of-Favor Stocks We Keep Off Our Radar

3 Out-of-Favor Stocks We Keep Off Our Radar

ARHS : 7.86 (-0.51%)
INGR : 98.75 (+1.29%)
RGEN : 144.24 (+0.21%)
Repligen Announces Publication of the Company’s 2025 Corporate Sustainability Report

WALTHAM, Mass., May 20, 2026 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced the digital publication of...

RGEN : 144.24 (+0.21%)
Q1 Rundown: Repligen (NASDAQ:RGEN) Vs Other Drug Development Inputs & Services Stocks

Q1 Rundown: Repligen (NASDAQ:RGEN) Vs Other Drug Development Inputs & Services Stocks

RGEN : 144.24 (+0.21%)
Why Repligen (RGEN) Stock Is Trading Up Today

Why Repligen (RGEN) Stock Is Trading Up Today

RGEN : 144.24 (+0.21%)
1 Growth Stock with Explosive Upside and 2 Facing Headwinds

1 Growth Stock with Explosive Upside and 2 Facing Headwinds

PAR : 16.88 (+0.84%)
VEEV : 190.12 (+0.22%)
RGEN : 144.24 (+0.21%)
Repligen, AdaptHealth, and IQVIA Stocks Trade Down, What You Need To Know

Repligen, AdaptHealth, and IQVIA Stocks Trade Down, What You Need To Know

RGEN : 144.24 (+0.21%)
AHCO : 10.22 (+0.59%)
IQV : 207.85 (-0.54%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Strengthening short term outlook on maintaining the current direction.

See More Share

Business Summary

Repligen Corporation is a leading provider of advanced bioprocessing technologies and solutions used by large biopharmaceutical companies and contract manufacturing organizations for manufacturing biologic drugs, such as monoclonal antibodies (mAbs) and gene therapies. Repligen earns revenues from the...

See More

Key Turning Points

3rd Resistance Point 149.02
2nd Resistance Point 147.10
1st Resistance Point 145.67
Last Price 144.24
1st Support Level 142.32
2nd Support Level 140.40
3rd Support Level 138.97

See More

52-Week High 175.77
Fibonacci 61.8% 147.20
Last Price 144.24
Fibonacci 50% 138.38
Fibonacci 38.2% 129.56
52-Week Low 100.99

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.